BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, May 13, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 30, 2015
View Archived Issues
New data on the efficacy and safety of MM-141 in combination therapy
Read More
Urinary proteins linked to adverse outcomes in critically ill patients with AKI
Read More
Boehringer Ingelheim divulges ENaC blockers
Read More
Roche reports development of mGluR5 antagonists
Read More
Spinifex Pharmaceuticals discloses new AT2 antagonists for pain
Read More
Rhizen Pharmaceuticals presents PI3Kdelta/gamma inhibitors
Read More
Agios Pharmaceuticals discloses new inhibitors of mutant IDH2
Read More
Reata enrolls first patient in phase II/III study of RTA-408 in Friedreich's ataxia
Read More
Phase II results presented for combination immunotherapy in pancreatic cancer
Read More
FDA grants orphan drug designation to tarextumab in pancreatic and small-cell lung cancer
Read More
Heat Biologics presents immunological data on HS-410 in non-muscle invasive bladder cancer
Read More
Celldex Therapeutics and BMS begin study of varlilumab and Opdivo
Read More
Amgen offers overview of fourth quarter 2014
Read More
Opexa files registration statement for rights offering
Read More
RedHill Biopharma provides update on RHB-104 for Crohn's disease
Read More
Taxus Cardium updates on ASPIRE trial of angiogenic gene therapy in angina patients
Read More
FDA awards orphan drug designation to Silenseed's siG12D-LODER for pancreatic cancer
Read More
AstraZeneca establishes four CRISPR-based research collaborations
Read More
FDA clears MediciNova's IND application for MN-001 in NASH
Read More
Efficacy study compares Flublok Quadrivalent to a traditional flu vaccine
Read More
Exonate presents small-molecules inhibitors of SRPK1 with potential for prostate cancer
Read More
SBIR grant supports Crinetics' development of kisspeptin receptor antagonists to treat PCOS
Read More
Goodwin Biotechnology and Transporin establish technology collaboration
Read More
Lenvatinib increases progression-free survival in phase I/II renal cancer study
Read More
Valneva license to Immune Targeting Systems for HBV vaccines with the IC31 adjuvant
Read More
FDA awards breakthrough therapy designation to Intercept's obeticholic acid for NASH with fibrosis
Read More
FDA approves Bristol-Myers Squibb's Evotaz for HIV-1 infection
Read More